Indeed, low circulating levels of adropin, which has potent powerful organ-protective properties, are associated with the presence of cardiovascular and metabolic risk factors, such as atherosclerosis, hypertension, obesity, insulin resistance, chronic kidney disease and dyslipidaemia. Here, ENHO is linked to inherited lipid metabolism disorder.